HLEMX | RNWBX | HLEMX / RNWBX | |
Total Expense Ratio | 1.14 | 1.67 | 68% |
Annual Report Gross Expense Ratio | 1.14 | 1.67 | 68% |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 8.810 | 11.298 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 250 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 440M | 67.7B | 1% |
Annual Yield % from dividends | 1.51 | 0.13 | 1,119% |
Returns for 1 year | -1.71 | 7.09 | -24% |
Returns for 3 years | -6.66 | 32.44 | -21% |
Returns for 5 years | -18.92 | 28.56 | -66% |
Returns for 10 years | -8.14 | 54.60 | -15% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THISX | 77.36 | -0.37 | -0.48% |
T. Rowe Price Health Sciences I | |||
GTLSX | 13.77 | -0.13 | -0.94% |
Glenmede Long/Short Eq Ptf Instl Shrs | |||
VKSCX | 18.36 | -0.26 | -1.40% |
Virtus KAR Small-Mid Cap Core C | |||
VVSCX | 11.07 | -0.20 | -1.77% |
VALIC Company I Small Cap Value | |||
GTTTX | 30.35 | -0.55 | -1.78% |
Goldman Sachs Small Cp Val Insghts Inv |